does glp 1 cause insulin resistance Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? Trends in insulin resistance: insights

One is to eat a small, protein-rich snack before going out

Suspected side effects of GLP-1 medicines should be reported via the MHRA Yellow Card scheme (yellowcard

This stabilizes blood sugar and reduces insulin-driven fat storage

However, long-term human safety data is still being established

Can it really help fight cancer

In human clinical use, reported side effects are generally mild and transient: Mild injection site redness or discomfort (resolves within hours) Transient nausea in some patients, particularly early in the protocol Mild dizziness or light-headedness (rare, typically dose-related) Temporary fatigue in the first few days (often a sign of active tissue remodeling) No significant systemic toxicity, organ damage, hormonal suppression, or addiction potential has been documented in the published literature